The dual effect of morphine on tumor development
Open Access
- 23 November 2018
- journal article
- review article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 21 (6) , 695-701
Abstract
Morphine is a classic opioid drug used for reducing pain and is commonly prescribed as an effective drug to control cancer pain. Morphine has a direct role in the central nervous system to relieve pain, but because of its peripheral functions, morphine also has some side effects, such as nausea, constipation, and addiction (Gupta et al. in Sci World J 2015:10, 2015 ). In addition to its analgesic effect, the role of morphine in tumor development is an important question that has been investigated for many years with conflicting results. Numerous studies suggest that morphine has a role in both promoting and inhibiting tumor growth. In this extensive review, we attempt to comprehensively understand the effects of morphine and summarize both its positive and negative influences on various aspects of tumors, including tumor growth, angiogenesis, metastasis, inflammation, and immunomodulation.Keywords
This publication has 51 references indexed in Scilit:
- Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancerBMC Cancer, 2017
- Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenograftsScientific Reports, 2016
- Opioid‐Induced Central Immune Signaling: Implications for Opioid AnalgesiaHeadache: The Journal of Head and Face Pain, 2015
- Morphine for the Treatment of Pain in Sickle Cell DiseaseThe Scientific World Journal, 2015
- Morphine modulates cell proliferation through mir133b & mir128 in the neuroblastoma SH-SY5Y cell lineBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- Chronic high‐dose morphine treatment promotes SH‐SY5Y cell apoptosis via c‐Jun N‐terminal kinase‐mediated activation of mitochondria‐dependent pathwayThe FEBS Journal, 2009
- κ-Opioid receptor potentiates apoptosis via a phospholipase C pathway in the CNE2 human epithelial tumor cell lineBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2000
- Fas-mediated cell death promoted by opioidsNature, 1999
- The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptorsEuropean Journal of Pharmacology, 1996
- Morphine effect on proliferation of normal and tumor cells of immune originImmunology Letters, 1993